Login / Signup

Oocyte vitrification for fertility preservation following COS does not delay the initiation of neoadjuvant chemotherapy for breast cancer compared to IVM.

Ines SellamiAnne MayeurAlexandra BenoitFayçal ZeghariMaeliss PeignéJad RoufaelMichaël GrynbergCharlotte Sonigo
Published in: Journal of assisted reproduction and genetics (2023)
The indication of NAC for BC should not be considered as an impediment to urgent COS for oocyte vitrification for FP.
Keyphrases
  • neoadjuvant chemotherapy
  • locally advanced
  • lymph node
  • sentinel lymph node
  • transcription factor
  • childhood cancer
  • rectal cancer
  • genome wide analysis